Convalescent Plasma Antibody Levels and the Risk of Death from Covid-19

Michael J. Joyner(WinnMed), Arturo Casadevall(Johns Hopkins University), Chad C. Wiggins(Johns Hopkins University), Andrew J. Clayburn(Johns Hopkins University), Elizabeth R. Lesser(Mayo Clinic), Camille M. van Buskirk(Johns Hopkins University), Stephen A. Klassen(Brock University), Allan M. Klompas(Mayo Clinic in Florida), Rickey E. Carter(Mayo Clinic in Florida), Katelyn A. Bruno(Mayo Clinic in Florida), Emily R. Whelan(Mayo Clinic in Florida), John R.A. Shepherd(Johns Hopkins University), Kylie J. Andersen(Johns Hopkins University), James R. Stubbs(Johns Hopkins University), Jeffrey L. Winters(Mayo Clinic), Janis E. Blair(Mayo Clinic Hospital), Noud van Helmond(Cooper University Hospital), Philippe R. Bauer(Mayo Clinic in Florida), Jonathon W. Senefeld(University of Illinois Urbana-Champaign), Robert F. Rea(Harvard–MIT Division of Health Sciences and Technology), Vitaly Herasevich(Mayo Clinic in Florida), Matthew A. Sexton(Johns Hopkins University), Katie L. Kunze(Mayo Clinic in Arizona), R. Scott Wright(Pacific Heart Institute), Patrick W. Johnson(Mayo Clinic in Florida), Kathryn F. Larson(Johns Hopkins University), Sarah E. Baker(Johns Hopkins University), Juan G. Ripoll(Johns Hopkins University), Nicole Verdun(Center for Biologics Evaluation and Research), Riley J. Regimbal(Johns Hopkins University), Nigel Paneth, John R. Mills(Mayo Clinic), DeLisa Fairweather(Mayo Clinic), Elitza S. Theel(Mayo Clinic), David O. Hodge(WinnMed), Matthew Buras, Joshua J. Dennis(Johns Hopkins University), Peter Marks(Center for Biologics Evaluation and Research), Juan C. Diaz Soto(Johns Hopkins University), Matthew N.P. Vogt(Johns Hopkins University)
New England Journal of Medicine
January 13, 2021
Cited by 553


Related Papers